Polivy Injection, Powder, Lyophilized, For Solution
Product Images NDC 50242-103

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Polivy (NDC 50242-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Polivy 01)

FDA Label Image

Principal Display Panel (140 mg Vial Carton)

Principal Display Panel (140 mg Vial Carton)
Polivy is a cytotoxic drug available in a single-dose vial with 140mg per vial. It is administered through intravenous infusion and requires reconstitution and dilution before administration. Users are advised to discard any unused portion, and the drug should only be handled by qualified healthcare professionals. The National Drug Code (NDC) for this drug is 50242-105-01, and it is manufactured by Genentech.*
FDA Label Image

Principal Display Panel (30 mg Vial Carton)

Principal Display Panel (30 mg Vial Carton)
Polivy® (polatuzumab vedotin-piiq) is a cytotoxic agent for intravenous infusion only. It comes as a single-dose vial which should be reconstituted and diluted before use. Unused portions should be discarded carefully. It is manufactured and distributed by Genentech and has the National Drug Code (NDC) 50242-103-01.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.